Similarly, ADA levels are associated with disease activation in patients with other autoimmune diseases, such as systemic lupus erythematosus, juvenile idiopathic arthritis, rheumatoid arthritis, and Still’s disease (Torgutalp et al., 2017). Here, ADA is linked to autoimmune disease.